Consultation has opened for the July 2023 Pharmaceutical Benefits Advisory Committee (PBAC) agenda. The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines submitted for PBAC consideration. The PBAC considers these public consultation inputs when considering the clinical and economic evidence presented...
Closes 24 May 2023
Consultation is now open for applications that are anticipated to be considered by the Medical Services Advisory Committee (MSAC) on 27-28 July 2023 MSAC values consultation input from individuals and organisations with an interest in an application that it is considering, including experience of the medical conditions, services or technologies being addressed by the application. ...
Closes 10 June 2023
Consultation is now open for applications that are anticipated to be considered by the PICO Advisory Sub-Committee (PASC) of the Medical Services Advisory Committee (MSAC) on 13-14 April 2023. PASC values consultation input from individuals and organisations with an interest in an application that it is considering, including experience of the medical conditions, services or technologies...
Closed 10 March 2023
Consultation is now open for applications that are anticipated to be considered by the Medical Services Advisory Committee (MSAC) on 30 - 31 March 2023. MSAC values consultation input from individuals and organisations with an interest in an application that it is considering, including experience of the medical conditions, services or technologies being addressed by the...
Closed 10 February 2023
Consultation has closed for the March 2023 Pharmaceutical Benefits Advisory Committee (PBAC) agenda. The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines submitted for PBAC consideration. The PBAC considers these public consultation inputs when considering the clinical and economic evidence...
Closed 25 January 2023
The views and experiences of patients (consumers) and their carers on medicines and medical services and products play an important part in informing advice to the Australian Government on what should be provided. A process called health technology assessment (HTA) is used to inform this advice and includes consideration of the views and experiences of patients and...
Closed 22 January 2023
The views and experiences of patients (consumers) and their carers on medicines and medical services and products play an important part in informing advice to the Australian Government on what should be provided. A process called health technology assessment (HTA) is used to inform this advice and includes consideration of the views and experiences of patients and carers. The Office...
Closed 22 January 2023